Search Results

retainer support. Get clarity, fix chaos, and grow faster with proven business strategy frameworks tailored for founders If that’s you, we offer something different: Ongoing strategic support with monthly firepower. between meetings 🗺️ Ongoing roadmap evolution ⏱️ Approx. 15–20 hours/month of dedicated strategic support Make sure the business side doesn’t kill the science. More about me → Let’s Build Your Strategy.

Biotech Scaling Vault The no‑BS hub for biotech operators who want results. biotech teams confuse fast progress with real scalability. 2 min read Scaling Framework for Biotech: The 3 Blind Spots That Stall Growth Most biotech CEOs fail Leadership is spread too thin across science + business. 👉 Over the next few weeks, you’ll receive 5 FAQ Q1: What is the Biotech Scaling Vault?

The Biotech Risk If left unchecked, these blind spots destroy leverage. The company “feels busy” but isn’t truly compounding. System Fix: Build a Decision Chain Blueprint —map who owns, who decides, and who supports each core function Together, they form the triad of scalable biotech execution. Want to run a complete “3-Lens Scale Audit” inside your biotech?

In early-stage biotech, your business model is not just about how you make money. Biotech business models succeed when founders align science, market, and money, not when they chase the your biotech business model does not mean resisting investor input or market signals. Your biotech business model is only as strong as what keeps it balanced. Founder Questions: Is Your Biotech Business Model Still Yours?

. 👉 Biotech founders face unique challenges: Complex regulations Lengthy development timelines Intense Every stage—whether it’s research, development, clinical trials, or commercialization—demands precision In the end, systems are the backbone of any biotech business that wants to move beyond the startup phase Ask yourself: Are your systems supporting your strategy, or are you building a bridge to nowhere? Align Systems With Strategy 👉 Make sure every system you build directly supports your strategic goals

Strong biotech licensing isn’t about validation; it’s about the discipline to protect your future degrees It shows up when founders treat biotech licensing like a moment of validation instead of a strategic Strong biotech licensing is built on three levers: clarity, flexibility, and economic coherence, the Strategic Takeaway – Clean Biotech Licensing 👉 The hard truth: Investors don’t just invest in science Attila runs focused strategy consultations for biotech founders who are ready to lead with clarity, not